BDTX- Black Diamond Therapeutics, Inc.

Name: Black Diamond Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Black Diamond Therapeutics, Inc. (BDTX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 47 sells. BDTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Behbahani Ali	93.6K	$267.1K	-
Dir	Raman Prakash	37.1K	$106.0K	-
Dir	Dhingra Kapil	30.6K	$87.2K	-
Dir	Campbell Shannon	30.6K	$87.2K	-
Dir	Kulkarni Samarth	30.6K	$87.2K	-

Activity

Buys and sells only

Transactions

10 filings · page 5

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Nov 16, 2020	Versant Venture Capital Vi, L.P.64	10% Owner	Sell	4,700	$33.74	$158,586.75	-
Nov 12, 2020	Hatzis-Schoch Brent82	See Remarks	Sale+OE	4,078	$33.99	$138,606.55	-25.7%
Nov 12, 2020	Bolzon Bradley J Phd75	Director, 10% Owner	Sell	15,598	$34.15	$532,641.99	-
Nov 12, 2020	Versant Venture Capital Vi, L.P.64	10% Owner	Sell	15,598	$34.15	$532,641.99	-
Nov 11, 2020	Roberts Christopher D.	Chief Scientific Officer	Sale+OE	5,000	$34.90	$174,500.00	-100%
Nov 11, 2020	Bolzon Bradley J Phd75	Director, 10% Owner	Sell	39,583	$34.11	$1,350,353.79	-0.1%
Nov 11, 2020	Versant Venture Capital Vi, L.P.64	10% Owner	Sell	39,583	$34.11	$1,350,353.79	-0.1%
Nov 9, 2020	Leggett Thomas	Chief Financial Officer	Sale+OE	3,000	$32.96	$98,891.70	-100%
Nov 9, 2020	Bolzon Bradley J Phd75	Director, 10% Owner	Sell	9,400	$33.08	$310,948.63	-
Nov 9, 2020	Versant Venture Capital Vi, L.P.64	10% Owner	Sell	9,400	$33.08	$310,948.63	-

← PrevPage 5Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC